Clinical Trials Browser

Phase 1 × Completed × RO5126766 × Clear all

NCT03681483 2024-07-10

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

Phase 1 Completed

Advanced Non-small Cell Lung Cancer

NCT00773526 2016-11-02

A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.

Phase 1 Completed

Neoplasms